Cargando…

Anti-Osteoclastogenic Activity of Praeruptorin A via Inhibition of p38/Akt-c-Fos-NFATc1 Signaling and PLCγ-Independent Ca(2+) Oscillation

BACKGROUND: A decrease of bone mass is a major risk factor for fracture. Several natural products have traditionally been used as herbal medicines to prevent and/or treat bone disorders including osteoporosis. Praeruptorin A is isolated from the dry root extract of Peucedanum praeruptorum Dunn and h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeon, Jeong-Tae, Kim, Kwang-Jin, Choi, Sik-Won, Moon, Seong-Hee, Park, Young Sik, Ryu, Byung Jun, Oh, Jaemin, Kim, Min Seuk, Erkhembaatar, Munkhsoyol, Son, Young-Jin, Kim, Seong Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931687/ https://www.ncbi.nlm.nih.gov/pubmed/24586466 http://dx.doi.org/10.1371/journal.pone.0088974

Ejemplares similares

Anti-osteoclastogenic activity of matairesinol via suppression of p38/ERK-NFATc1 signaling axis
por: Choi, Sik-Won, et al.
Publicado: (2014)

Fisetin Inhibits Osteoclast Differentiation via Downregulation of p38 and c-Fos-NFATc1 Signaling Pathways
por: Choi, Sik-Won, et al.
Publicado: (2012)

Oat Seedlings Extract Inhibits RANKL-Induced c-Fos/NFATc1 Transcription Factors in the Early Stage of Osteoclast Differentiation
por: Yang, Ji Yeong, et al.
Publicado: (2022)

Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways
por: Shang, Wei, et al.
Publicado: (2016)

Effect of Usnic Acid on Osteoclastogenic Activity
por: Kim, Kwang-Jin, et al.
Publicado: (2018)

Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
por: Erkhembaatar, Munkhsoyol, et al.
Publicado: (2015)

Inhibitory Effect of Chrysanthemum zawadskii Herbich var. latilobum Kitamura Extract on RANKL-Induced Osteoclast Differentiation
por: Gu, Dong Ryun, et al.
Publicado: (2013)

Parthenolide inhibits osteoclast differentiation and bone resorbing activity by down-regulation of NFATc1 induction and c-Fos stability, during RANKL-mediated osteoclastogenesis
por: Kim, Ju-Young, et al.
Publicado: (2014)

Ginsenoside Rg2 inhibits osteoclastogenesis by downregulating the NFATc1, c-Fos, and MAPK pathways
por: Lee, Sung-Hoon, et al.
Publicado: (2023)

The Effects of Aronia melanocarpa ‘Viking’ Extracts in Attenuating RANKL-Induced Osteoclastic Differentiation by Inhibiting ROS Generation and c-FOS/NFATc1 Signaling
por: Ghosh, Mithun, et al.
Publicado: (2018)

Gleditsiae fructus regulates osteoclastogenesis by inhibiting the c‑Fos/NFATc1 pathway and alleviating bone loss in an ovariectomy model
por: Cho, Chang-Young, et al.
Publicado: (2023)

Inhibitory Effect of Purpurogallin on Osteoclast Differentiation In Vitro through the Downregulation of c-Fos and NFATc1
por: Kim, Kiryeong, et al.
Publicado: (2018)

Stauntonia hexaphylla (Lardizabalaceae) leaf methanol extract inhibits osteoclastogenesis and bone resorption activity via proteasome-mediated degradation of c-Fos protein and suppression of NFATc1 expression
por: Cheon, Yoon-Hee, et al.
Publicado: (2015)

Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression
por: Kim, Eun-Jung, et al.
Publicado: (2018)

RCANs regulate the convergent roles of NFATc1 in bone homeostasis
por: Kim, Jung Ha, et al.
Publicado: (2016)

Umbelliferone Prevents Lipopolysaccharide-Induced Bone Loss and Suppresses RANKL-Induced Osteoclastogenesis by Attenuating Akt-c-Fos-NFATc1 Signaling
por: Kwak, Sung Chul, et al.
Publicado: (2019)

Betulin Suppresses Osteoclast Formation via Down-Regulating NFATc1
por: Kim, Kwang-Jin, et al.
Publicado: (2018)

Rosiglitazone suppresses RANKL‐induced NFATc1 autoamplification by disrupting the physical interaction between NFATc1 and PPARγ
por: Park, Kyeong‐Lok, et al.
Publicado: (2018)

Melatonin Attenuates RANKL-Induced Osteoclastogenesis via Inhibition of Atp6v0d2 and DC-STAMP through MAPK and NFATc1 Signaling Pathways
por: Kim, Seong-Sik, et al.
Publicado: (2022)

The osteocyte and its osteoclastogenic potential
por: Marahleh, Aseel, et al.
Publicado: (2023)

Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB
por: Kang, Moo Rim, et al.
Publicado: (2014)

MIP-1δ Activates NFATc1 and Enhances Osteoclastogenesis: Involvement of Both PLCγ2 and NFκB Signaling
por: Weber, Kristy L., et al.
Publicado: (2012)

Do We Use Methylation of NFATC1 and FOS Genes As a Biomarker for Postmenopausal Osteoporosis?
por: Kalkan, R, et al.
Publicado: (2021)

BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1
por: Zhang, Yufeng, et al.
Publicado: (2022)

Biological Activities and Pharmacokinetics of Praeruptorins from Peucedanum Species: A Systematic Review
por: Sarkhail, Parisa, et al.
Publicado: (2013)

Endothelium-dependent vasorelaxant effects of praeruptorin a in isolated rat thoracic aorta
por: Li, Zhenkun, et al.
Publicado: (2022)

Amorphigenin inhibits Osteoclast differentiation by suppressing c-Fos and nuclear factor of activated T cells
por: Kim, Bong Gyu, et al.
Publicado: (2010)

The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues
por: Zupan, Janja, et al.
Publicado: (2012)

The Brown Algae Ishige sinicola Extract Ameliorates Ovariectomy-Induced Bone Loss in Rats and Suppresses Osteoclastogenesis through Downregulation of NFATc1/c-Fos
por: Kim, Mihyang, et al.
Publicado: (2022)

Water extract of Cnidii Rhizoma suppresses RANKL-induced osteoclastogenesis in RAW 264.7 cell by inhibiting NFATc1/c-Fos signaling and prevents ovariectomized bone loss in SD-rat
por: Lee, Ka-Yeon, et al.
Publicado: (2019)

Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca(2+)-NFATc1 signaling pathway
por: Zeng, Xiang-zhou, et al.
Publicado: (2019)

Modern Interpretation of Giant Cell Tumor of Bone: Predominantly Osteoclastogenic Stromal Tumor
por: Kim, Yuhree, et al.
Publicado: (2012)

Tusc2/Fus1 regulates osteoclast differentiation through NF-κB and NFATc1
por: Kim, Inyoung, et al.
Publicado: (2017)

Pharmacokinetics of dl-praeruptorin A after single-dose intravenous administration to rats with liver cirrhosis
por: Zhang, Z, et al.
Publicado: (2011)

Protein phosphatase 1 regulatory subunit 18 suppresses the transcriptional activity of NFATc1 via regulation of c-fos
por: Yasuda, Kazuma, et al.
Publicado: (2021)

Treatment of eggshell with casein phosphopeptide reduces the severity of ovariectomy-induced bone loss
por: Kim, Jung-Hoon, et al.
Publicado: (2013)

Regulation of NFATc1 in Osteoclast Differentiation
por: Kim, Jung Ha, et al.
Publicado: (2014)

PLCγ1 in dopamine neurons critically regulates striatal dopamine release via VMAT2 and synapsin III
por: Kim, Hye Yun, et al.
Publicado: (2023)

The Coumarin Derivative 5′-Hydroxy Auraptene Suppresses Osteoclast Differentiation via Inhibiting MAPK and c-Fos/NFATc1 Pathways
por: Abdallah, Basem M., et al.
Publicado: (2019)

A Nitrobenzoyl Sesquiterpenoid Insulicolide A Prevents Osteoclast Formation via Suppressing c-Fos-NFATc1 Signaling Pathway
por: Tan, Yanhui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6pgblrrlo0vu57v5816uc0g3v5